Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Evonik makes specialty chemicals that help other companies improve their products, from animal feed to car tires.
Evonik is a specialty chemicals company. It does not make big-ticket consumer products you'd recognize on a shelf. Instead, it sells the ingredients, additives, and advanced materials that other manufacturers build into their own products—things like amino acids that make animal feed more nutritious, silica that makes tires grip better, and specialized polymers for medical implants.
The business splits into a few main pieces. One makes feed additives, particularly an amino acid called methionine that helps chickens and pigs grow efficiently; Evonik is one of the world's largest producers. Another segment makes specialty additives for coatings, plastics, and consumer goods. A third, called Smart Materials, makes high-performance polymers, hydrogen peroxide, and silica used in tires and industrial processes. There's also a health care and technology arm focused on drug-delivery ingredients and lipids used in mRNA vaccines. Customers pay for these because getting the chemistry right is hard, and Evonik's products often solve a specific problem better than a generic substitute would. The company is a classic German industrial spin-off story: it used to be part of the mining conglomerate RAG, went public in 2013, and has since been reshaping itself toward higher-margin specialty chemicals while shedding lower-margin commodity businesses. That "sell the boring stuff, keep the clever stuff" strategy has been the central theme for years. It sold its methacrylate business and has been trimming its portfolio, though it has faced pressure because chemicals demand is cyclical and Europe's energy costs have been painful for energy-intensive producers.
Financially, Evonik is a mid-sized player with annual revenue in the low-to-mid teens of billions of euros (about €15 billion recently), and it pays a steady dividend. The stock has struggled at times as the whole European chemicals sector deals with weak industrial demand and stiff competition from cheaper producers in Asia and the Middle East. One fun historical note: the company traces its roots back to the 1800s and even managed the estate of the famous von der Leyen family, but the modern version is a focused specialty chemicals operation betting its future on innovation-heavy niches rather than volume.
Saved answer · last researched 26 Oct 2026